This year not a good year for NVO and doubt it will rise to $60 next Fri. Hope next year will be a good year for NVO and while waiting, I will continue to sell covered calls to earn premium [Miser]
| Side | Price | Filled | Realized P&L |
|---|---|---|
| Sell Open | 0.72 3Lot(s) | -- Closed |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- Mortimer Arthur·2025-10-31TOPNovo has the best obesity drugs but unfortunately, it appears to be in panic mode and it is doing very bad decisions like the acquisition of Metsera, which is just an empty bag2Report
- Venus Reade·2025-10-31TOPPfizer study to sue Novo for high bidding, that means it was a really successful move from Novo. Bravo for Novo management and this is expected from a solo owner's company.1Report
- Sarohiwal·2025-11-08There were recent changes in leadership level within NVO which is still on-going maybe Q1-2026 will be better time to enter for NVO.LikeReport
- 逆天邪神云澈·2025-10-31have 300 shares but hope to accumulate max 2000LikeReport
- Kristina_·2025-10-30Are you holding NVO shares?[Surprised]LikeReport